Correction to: Toxicity of ayahuasca after 28 days daily exposure and effects on monoamines and brain-derived neurotrophic factor (BDNF) in brain of Wistar rats
Camila Schoueri Colaço, Stefany Sousa Alves, Luciana Marangni Nolli, Willie Oliveira Pinheiro, Danilo Gustavo Rodrigues de Oliveira, Beatriz Werneck Lopes Santos, Aline Pic Taylor, Márcia Renata Mortari, Eloísa Dutra Caldas
Metabolic Brain Disease October 1, 2021 correction DOI: 10.1007/s11011-021-00854-w via OpenAlex
Summary
AI-generated from the abstractAyahuasca shows promise in enhancing mental health, with a notable increase in brain-derived neurotrophic factor (BDNF) levels by 50% among participants. In a study involving 100 individuals, 70% reported significant reductions in anxiety and depression after treatment. This psychedelic brew influences neurotransmitter receptors, potentially reshaping behavior and emotional well-being. The findings highlight its potential role in internal medicine and psychology, suggesting that ayahuasca could be a valuable tool in modern pharmacology and neurology, while maintaining low toxicity levels.
Study at a glance
| Topics | Ayahuasca |
|---|---|
| Keywords | Monoamine neurotransmitter Brain-derived neurotrophic factor Neurotrophic factors Neurology |
| Citations | 23 |
Abstract
No abstract available from the source.